21-41739813-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020639.3(RIPK4):​c.*1025G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00483 in 152,356 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0048 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

RIPK4
NM_020639.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.325

Publications

1 publications found
Variant links:
Genes affected
RIPK4 (HGNC:496): (receptor interacting serine/threonine kinase 4) The protein encoded by this gene is a serine/threonine protein kinase that interacts with protein kinase C-delta. The encoded protein can also activate NFkappaB and is required for keratinocyte differentiation. This kinase undergoes autophosphorylation. [provided by RefSeq, Jul 2008]
RIPK4 Gene-Disease associations (from GenCC):
  • Bartsocas-Papas syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ectodermal dysplasia syndrome
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 21-41739813-C-A is Benign according to our data. Variant chr21-41739813-C-A is described in ClinVar as Benign. ClinVar VariationId is 895208.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00483 (736/152356) while in subpopulation NFE AF = 0.0077 (524/68032). AF 95% confidence interval is 0.00716. There are 3 homozygotes in GnomAd4. There are 360 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020639.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RIPK4
NM_020639.3
MANE Select
c.*1025G>T
3_prime_UTR
Exon 8 of 8NP_065690.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RIPK4
ENST00000332512.8
TSL:1 MANE Select
c.*1025G>T
3_prime_UTR
Exon 8 of 8ENSP00000332454.3P57078-2
RIPK4
ENST00000352483.3
TSL:5
c.*1025G>T
3_prime_UTR
Exon 9 of 9ENSP00000330161.2P57078-1
ENSG00000236883
ENST00000423276.1
TSL:3
n.299+142C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00484
AC:
737
AN:
152238
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00118
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00569
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00770
Gnomad OTH
AF:
0.00669
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
88
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
66
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66
Other (OTH)
AF:
0.00
AC:
0
AN:
8
GnomAD4 genome
AF:
0.00483
AC:
736
AN:
152356
Hom.:
3
Cov.:
33
AF XY:
0.00483
AC XY:
360
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00118
AC:
49
AN:
41574
American (AMR)
AF:
0.00568
AC:
87
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
25
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4828
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00770
AC:
524
AN:
68032
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00503
Hom.:
1
Bravo
AF:
0.00510
Asia WGS
AF:
0.00260
AC:
10
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Bartsocas-Papas syndrome 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.2
DANN
Benign
0.75
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73216989; hg19: chr21-43159973; API